← FDA DRUG APPROVALS

FDA ANDA · ANDA070714

HALOPERIDOL

Sponsor: WATSON LABS

APPLICATION
ANDA070714
TYPE
ANDA
ORIGINAL APPROVAL
1988-05-17
LATEST ACTION
2015-11-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HALOPERIDOLDiscontinued
HALOPERIDOL LACTATE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

2015-11-03Labeling · Supplement 6AP
1990-09-11Manufacturing (CMC) · Supplement 4AP
1989-12-22Labeling · Supplement 3AP
1989-02-09Manufacturing (CMC) · Supplement 1AP
1988-05-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →